US Edition
Sandoz Does Not Want to Produce in the Usa Despite Customs Pressure
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Sandoz CEO Saynor remains in the process: the generics specialist "currently does not" plan to build a production in the USA. "Even with a tax of 250 percent"
The head of the Swiss pharmaceutical company Sandoz, Richard Saynor, remains in the process: the generics specialist "currently does not plan to build a production in the USA". "Even with a tax of 250 percent", Saynor said in an interview with the newspaper "L'Agefi" on Friday. Sandoz operates a large production site in Kundl in Tyrol in Austria.
Sandoz considers itself relatively immune to the tariffs applied to imports into the United States. The generic drug giant's production is distributed among various European countries, with the notable exception of Switzerland, as well as in India.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
